[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE602004022515D1 - FENOFIBRATE TABLET AND METHOD OF PREPARING THEREOF - Google Patents

FENOFIBRATE TABLET AND METHOD OF PREPARING THEREOF

Info

Publication number
DE602004022515D1
DE602004022515D1 DE602004022515T DE602004022515T DE602004022515D1 DE 602004022515 D1 DE602004022515 D1 DE 602004022515D1 DE 602004022515 T DE602004022515 T DE 602004022515T DE 602004022515 T DE602004022515 T DE 602004022515T DE 602004022515 D1 DE602004022515 D1 DE 602004022515D1
Authority
DE
Germany
Prior art keywords
preparing
active ingredient
fenofibrate tablet
fenofibrate
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004022515T
Other languages
German (de)
Inventor
Jerome Besse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galenix Innovations Sas
Original Assignee
Galenix Innovations Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenix Innovations Sas filed Critical Galenix Innovations Sas
Publication of DE602004022515D1 publication Critical patent/DE602004022515D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

A method for the manufacture of a pharmaceutical composition containing the active ingredient fenofibrate or one of its derivatives, optionally in combination with a second active ingredient, in the form of tablets, characterized in that it comprises a compression step of the active ingredient and excipients by means of a dry method of granulation
DE602004022515T 2003-02-28 2004-02-27 FENOFIBRATE TABLET AND METHOD OF PREPARING THEREOF Expired - Lifetime DE602004022515D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0302520A FR2851734B1 (en) 2003-02-28 2003-02-28 PROCESS FOR THE PRODUCTION OF A PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS CONTAINING A FIBRATE AND COMPRESSES OBTAINED BY THE PROCESS
PCT/FR2004/050090 WO2004078108A2 (en) 2003-02-28 2004-02-27 Fibrate tablet and method for the production thereof

Publications (1)

Publication Number Publication Date
DE602004022515D1 true DE602004022515D1 (en) 2009-09-24

Family

ID=32843093

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004022515T Expired - Lifetime DE602004022515D1 (en) 2003-02-28 2004-02-27 FENOFIBRATE TABLET AND METHOD OF PREPARING THEREOF

Country Status (20)

Country Link
US (1) US20060177499A1 (en)
EP (1) EP1601346B1 (en)
JP (1) JP2006520770A (en)
CN (1) CN100479808C (en)
AT (1) ATE439125T1 (en)
AU (1) AU2004216869B2 (en)
BR (1) BRPI0407850A (en)
CA (1) CA2517429C (en)
DE (1) DE602004022515D1 (en)
FR (1) FR2851734B1 (en)
IL (1) IL170507A (en)
MA (1) MA27662A1 (en)
MX (1) MXPA05009113A (en)
NO (1) NO20054417L (en)
NZ (1) NZ542039A (en)
PL (1) PL378106A1 (en)
RU (1) RU2362547C2 (en)
TN (1) TNSN05203A1 (en)
WO (1) WO2004078108A2 (en)
ZA (1) ZA200506992B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006273849A (en) * 2005-03-02 2006-10-12 Aska Pharmaceutical Co Ltd Fenofibrate containing composition
US20090208576A1 (en) * 2006-03-31 2009-08-20 Gandhi Anilkumar S Orally Disintegrating Tablets
CA2638240C (en) * 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
JP5452051B2 (en) * 2009-03-27 2014-03-26 杏林製薬株式会社 An orally disintegrating tablet containing imidafenacin
CN102675748A (en) * 2012-05-22 2012-09-19 苏州新区华士达工程塑胶有限公司 Formula of weather-resistant polypropylene
US10966934B2 (en) * 2017-02-20 2021-04-06 Dsm Ip Assets B.V. Process for producing coated particles
KR102271734B1 (en) * 2020-10-21 2021-07-01 한국프라임제약주식회사 Pharmaceutical composition for dry-granulation process comprising multivitamins as active pharmaceutical ingredient

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627696B1 (en) * 1988-02-26 1991-09-13 Fournier Innovation Synergie NEW GALENIC FORM OF FENOFIBRATE
FR2730231B1 (en) * 1995-02-02 1997-04-04 Fournier Sca Lab COMBINATION OF FENOFIBRATE AND VITAMIN E, USE IN THERAPEUTICS
FR2758459B1 (en) * 1997-01-17 1999-05-07 Pharma Pass FENOFIBRATE PHARMACEUTICAL COMPOSITION HAVING HIGH BIODAVAILABILITY AND PROCESS FOR PREPARING THE SAME
FR2758461A1 (en) * 1997-01-17 1998-07-24 Pharma Pass PHARMACEUTICAL COMPOSITION HAVING HIGH BIOAVAILABILITY AND PROCESS FOR PREPARING THE SAME
FR2772615B1 (en) * 1997-12-23 2002-06-14 Lipha MULTILAYER TABLET FOR INSTANT RELEASE THEN PROLONGED ACTIVE SUBSTANCES
FR2774591B1 (en) * 1998-02-12 2000-05-05 Lipha PHARMACEUTICAL COMPOSITION COMPRISING THE ASSOCIATION OF METFORMIN AND FIBRATE AND THE USE THEREOF FOR THE PREPARATION OF MEDICINES FOR REDUCING HYPERGLYCEMIA
FR2781793B1 (en) * 1998-08-03 2001-07-20 Prographarm Lab PROCESS FOR PRODUCING COATED GABAPENTINE GRANULES
US6180138B1 (en) * 1999-01-29 2001-01-30 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
CA2407027C (en) * 2000-04-20 2011-02-15 Rtp Pharma Inc. Improved water-insoluble drug particle process
FR2819720B1 (en) * 2001-01-22 2004-03-12 Fournier Lab Sa NEW FENOFIBRATE TABLETS
US6534088B2 (en) * 2001-02-22 2003-03-18 Skyepharma Canada Inc. Fibrate-statin combinations with reduced fed-fasted effects
EP1364646A4 (en) * 2001-03-01 2005-08-03 Grelan Pharmaceutical Co Fenofibrate-containing composition

Also Published As

Publication number Publication date
JP2006520770A (en) 2006-09-14
BRPI0407850A (en) 2006-03-14
AU2004216869A1 (en) 2004-09-16
RU2362547C2 (en) 2009-07-27
US20060177499A1 (en) 2006-08-10
CA2517429A1 (en) 2004-09-16
WO2004078108A2 (en) 2004-09-16
ZA200506992B (en) 2007-04-25
EP1601346B1 (en) 2009-08-12
EP1601346A2 (en) 2005-12-07
FR2851734A1 (en) 2004-09-03
MA27662A1 (en) 2005-12-01
MXPA05009113A (en) 2006-05-31
CN1780606A (en) 2006-05-31
CA2517429C (en) 2012-04-17
ATE439125T1 (en) 2009-08-15
FR2851734B1 (en) 2006-06-09
NZ542039A (en) 2008-08-29
CN100479808C (en) 2009-04-22
TNSN05203A1 (en) 2007-06-11
IL170507A (en) 2011-11-30
NO20054417L (en) 2005-09-23
AU2004216869B2 (en) 2009-05-14
WO2004078108A3 (en) 2004-12-09
RU2005130155A (en) 2006-06-10
PL378106A1 (en) 2006-03-06

Similar Documents

Publication Publication Date Title
GB2402063B (en) Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof
EA200801926A1 (en) TABLETS OF PARACETAMOL WITH FAST DELIVERY
NO20062504L (en) Compositions and dosage forms for improved absorption
DE602005010788D1 (en) Pharmaceutical compositions for the safe administration of drugs used in the treatment of drug addiction
HRP20090194T1 (en) Dry granulated composition comprising emtricitabine and tenofovir df
DK1957110T3 (en) PROCEDURE FOR THE PREPARATION OF CHEWABLE DOSAGE FORMS FOR MEDICINE ADMINISTRATION AND PRODUCTS THEREOF
NO340679B1 (en) Pyridazine derivatives, pharmaceutical compositions comprising such and such compounds and preparations for use in therapeutically active substances for the treatment and prevention of diseases
ATE350377T1 (en) SUBSTITUTED 3-PYRROLIDINE INDOLE DERIVATIVES
DE60131760D1 (en) DEVICE FOR THE ADMINISTRATION OF PHYSIOLOGICALLY ACTIVE ACTIVE IN POWDER FORM
NO20064934L (en) Process for the preparation of a solid pharmaceutical composition
ATE354362T1 (en) STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING AN AMORPHIC ACTIVE INGREDIENT
ATE262893T1 (en) DOSAGE FORMS FOR THE TREATMENT OF ORAL MYCOSES
EA200801614A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING MONTELUKAST
IS7266A (en) Pharmaceutical forms containing acid-intolerant active substances and methods for their preparation
DE602004022515D1 (en) FENOFIBRATE TABLET AND METHOD OF PREPARING THEREOF
IS7424A (en) Oxazolidinone derivatives, methods of preparing them and pharmaceutical compositions containing them
NO20076120L (en) Stable nanoparticle formulations
EP1781629A4 (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
BRPI0518790A2 (en) pharmaceutical formulation, process for preparing a pharmaceutical formulation, product, and capsule or tablet
AR048672A1 (en) DISINTEGRATION TABLETS THAT INCLUDE LICARBAZEPINA
IS7383A (en) Dosage form with controlled release drug for administration
TR200301553A1 (en) New oral pharmaceutical formulations containing irbesartan active ingredient
ATE487492T1 (en) PHARMACEUTICAL COMPOSITION FOR TREATING DRUG DEPENDENCE
DK1499278T3 (en) Pharmaceutical dosage form exhibiting immediate release comprising polymorphic tibolone
ITMI20020872A1 (en) HYPERPHORINE DERIVATIVES THEIR USE AND FORMULATIONS CONTAINING THEM

Legal Events

Date Code Title Description
8364 No opposition during term of opposition